Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANAPTYSBIO, INC Director's Dealing 2025

Dec 23, 2025

32596_dirs_2025-12-23_dbe7a25d-4397-455f-ad95-46feff69f7d3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAPTYSBIO, INC (ANAB)
CIK: 0001370053
Period of Report: 2025-12-23

Reporting Person: Ware J. Anthony (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-12-23 Common Stock S 3900 $49.575 Disposed 9630 Direct

Footnotes

F1: In addition to the shares the Reporting Person owns reported in Table I, the Reporting Person also holds additional options to purchase up to an aggregate of 126,085 shares of common stock and 6,030 restricted stock units.